The deletion of two cancer genes, CHD1 and MAP3K7, improves how well tumors respond to cancer immunotherapy and could be used ...

A vitamin A byproduct could weaken the immune system's cancer-fighting ability, according to new Princeton University ...

Immunotherapy has transformed cancer care by helping the immune system recognize and destroy tumors. But new research from ...

From STAT’s Andrew Joseph: GSK said this morning that it would buy RAPT Therapeutics in a deal worth $2.2 billion, picking up ...

The experimental mRNA-based drug sharply reduced the risk of recurrence or death when combined with immunotherapy Keytruda, ...

In attempt to assess treatment patterns in advanced gastric cancer across racial and ethnic groups throughout the U.S., ...

In a Jan. 13th installation of the Stanford Cancer Institute’s “Breakthroughs in Cancer” lecture series, Lawrence Fong ...

Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body's own immune system to ...

CheckMate 9LA showed a 26% overall survival benefit for metastatic NSCLC patients treated with nivolumab and ipilimumab plus ...

Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune activation.

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...